• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Impax Laboratories Inc. (IPXL)

    -NasdaqGS
    42.40 Down 1.57(3.57%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 214,182   143,096   131,211   157,999  
    Cost of Revenue129,331  83,862  70,390  73,561  
    Gross Profit 84,851   59,234   60,821   84,438  
    Operating Expenses
    Research Development16,995  14,962  17,138  18,983  
    Selling General and Administrative48,309  50,160  42,208  38,888  
    Non Recurring1,494  960  327  1,066  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 18,053   (6,848) 1,148   25,501  
    Income from Continuing Operations
    Total Other Income/Expenses Net(15,648)118  548  378  
    Earnings Before Interest And Taxes2,405  (6,730)1,696  25,879  
    Interest Expense6,953  3,975  46  25  
    Income Before Tax(4,548)(10,705)1,650  25,854  
    Income Tax Expense(2,696)(4,372)1,530  10,117  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(1,852)(6,333)120  15,737  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (1,852) (6,333) 120   15,737  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (1,852) (6,333) 120   15,737  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.